mk2 Biotechnologies develops, produces and investigates peptides and proteins using a synthesis technology, enabling their cost-efficient production for various applications.

mk2 Biotechnologies

mk2 Biotechnologies | 1,216 followers on LinkedIn. Peptides &amp; Proteins for Mass Applications | mk2 Biotechnologies develops, produces and investigates peptides &amp; proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides &amp; proteins for a broad range of applications.

CEO at mohemian

Florian Scholochow

think bigger and never give up!!

René Schmidt

Head of Business Development | Biochemistry, Biophysics, Strategic Business Development

Priya Gurumoorthy, Ph.D.

Senior Advisor / Organisationsentwickler/ Projektcoach/ Founding & Business Angel

Thomas Leitgeb

The Finance Days at the analytica were a great opportunity for our CEO Konstantinos Antonopoulos to have a chat with a lot of fantastic people from the broader space and to develop creative solutions on the spot. If you're still around Munich and want to meet up, let us know! #proteins #peptides Christian Gnam IZB - Innovation and Start-up Center Biotechnology

Don't miss the opportunity to meet Priya Gurumoorthy, Ph.D. at the Meat Evolution Leaders Summit in Barcelona on Feb 7th/8th to check out our newest developments on growth factors and many more bioactive proteins.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 6, 2024 12:10 PM	adcd4d8a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 6, 2024 12:10 PM	fc3ba4e5
crunchbase trigger	general	Nov 6, 2024 12:10 PM	481dd7b1
crunchbase profile	general
li profile	general	Nov 6, 2024 12:10 PM	5ed40b1a
translate crunchbase fundingrounds	general
peers	general	Nov 6, 2024 12:10 PM	ecdcdd23
news basic	general	Nov 6, 2024 12:10 PM	622d01a7
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MK2

BIO:MK2

mk2 Biotechnologies